Synthetic retinoids for the secondary prevention of hepatocellular carcinoma.
Shafritz
D A
DA
D006528:Carcinoma, Hepatocellular / Q000517:prevention & control* / Q000821:virology; D002353:Carrier State / Q000821:virology; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D004279:DNA, Viral / Q000032:analysis*; D006515:Hepatitis B virus / Q000235:genetics*; D006801:Humans; D008113:Liver Neoplasms / Q000517:prevention & control* / Q000821:virology; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control* / Q000821:virology; D016609:Neoplasms, Second Primary / Q000517:prevention & control* / Q000821:virology; D012176:Retinoids / Q000627:therapeutic use; D014212:Tretinoin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D004279:DNA, Viral; D012176:Retinoids; D014212:Tretinoin; C034534:3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid